对促生成素治疗反应的分类。贫血病人的个案研究。

ANNA journal Pub Date : 1999-12-01

C Watson

{"title":"对促生成素治疗反应的分类。贫血病人的个案研究。","authors":"C Watson","doi":"","DOIUrl":null,"url":null,"abstract":"Hyporesponse to Epoetin alfa therapy can be minimized by categorizing patients on the basis of trends in hemoglobin/hematocrit levels and initiating a continuous quality improvement effort that focuses on subnormal outcomes. An algorithm is provided that clinicians can use to proactively assess common causes that contribute to hyporesponse and limit the effect on patient outcomes.","PeriodicalId":76998,"journal":{"name":"ANNA journal","volume":"26 6","pages":"629-32"},"PeriodicalIF":0.0000,"publicationDate":"1999-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Categorizing the response to Epoetin alfa therapy. Case study of the anemic patient.\",\"authors\":\"C Watson\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Hyporesponse to Epoetin alfa therapy can be minimized by categorizing patients on the basis of trends in hemoglobin/hematocrit levels and initiating a continuous quality improvement effort that focuses on subnormal outcomes. An algorithm is provided that clinicians can use to proactively assess common causes that contribute to hyporesponse and limit the effect on patient outcomes.\",\"PeriodicalId\":76998,\"journal\":{\"name\":\"ANNA journal\",\"volume\":\"26 6\",\"pages\":\"629-32\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1999-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ANNA journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ANNA journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

根据血红蛋白/红细胞压积水平的趋势对患者进行分类，并开始持续的质量改进工作，重点关注亚正常结果，可以最大限度地减少对Epoetin α治疗的低反应。提供了一种算法，临床医生可以使用它来主动评估导致低反应的常见原因，并限制对患者结果的影响。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

本刊更多论文

Categorizing the response to Epoetin alfa therapy. Case study of the anemic patient.

Hyporesponse to Epoetin alfa therapy can be minimized by categorizing patients on the basis of trends in hemoglobin/hematocrit levels and initiating a continuous quality improvement effort that focuses on subnormal outcomes. An algorithm is provided that clinicians can use to proactively assess common causes that contribute to hyporesponse and limit the effect on patient outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ANNA journal

自引率

0.00%

发文量